A carregar...
The prognostic value of CSCs biomarker CD133 in NSCLC: a meta-analysis
The prognostic value of cancer stem cells (CSCs) marker CD133 in non-small-cell lung cancer (NSCLC) remains controversial. We performed this meta-analysis of 32 eligible studies to clarify the prognostic value of CD133 and provide evidence for CSCs hypothesis. We calculated pooled hazard ratio (HR)...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5302932/ https://ncbi.nlm.nih.gov/pubmed/27489355 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10964 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|